These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17010604)

  • 1. Structure-based de novo design, synthesis, and biological evaluation of the indole-based PPARgamma ligands (I).
    Dong X; Zhang Z; Wen R; Shen J; Shen X; Jiang H
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5913-6. PubMed ID: 17010604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological activity of novel PPARgamma ligands based on rosiglitazone and 15d-PGJ2.
    Usui S; Suzuki T; Hattori Y; Etoh K; Fujieda H; Nishizuka M; Imagawa M; Nakagawa H; Kohda K; Miyata N
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1547-51. PubMed ID: 15745794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New PPARgamma ligands based on 2-hydroxy-1,4-naphthoquinone: computer-aided design, synthesis, and receptor-binding studies.
    Sundriyal S; Viswanad B; Bharathy E; Ramarao P; Chakraborti AK; Bharatam PV
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3192-5. PubMed ID: 18482837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonists.
    Peng YH; Coumar MS; Leou JS; Wu JS; Shiao HY; Lin CH; Lin WH; Lien TW; Chen X; Hsu JT; Chao YS; Huang CF; Lyu PC; Hsieh HP; Wu SY
    ChemMedChem; 2010 Oct; 5(10):1707-16. PubMed ID: 20734309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DASH: a novel analysis method for molecular dynamics simulation data. Analysis of ligands of PPAR-gamma.
    Salt DW; Hudson BD; Banting L; Ellis MJ; Ford MG
    J Med Chem; 2005 May; 48(9):3214-20. PubMed ID: 15857127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2D QSAR of PPARgamma agonist binding and transactivation.
    Rücker C; Scarsi M; Meringer M
    Bioorg Med Chem; 2006 Aug; 14(15):5178-95. PubMed ID: 16650995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities.
    Lu IL; Huang CF; Peng YH; Lin YT; Hsieh HP; Chen CT; Lien TW; Lee HJ; Mahindroo N; Prakash E; Yueh A; Chen HY; Goparaju CM; Chen X; Liao CC; Chao YS; Hsu JT; Wu SY
    J Med Chem; 2006 May; 49(9):2703-12. PubMed ID: 16640330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies.
    Mahindroo N; Wang CC; Liao CC; Huang CF; Lu IL; Lien TW; Peng YH; Huang WJ; Lin YT; Hsu MC; Lin CH; Tsai CH; Hsu JT; Chen X; Lyu PC; Chao YS; Wu SY; Hsieh HP
    J Med Chem; 2006 Feb; 49(3):1212-6. PubMed ID: 16451087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists.
    Kuhn B; Hilpert H; Benz J; Binggeli A; Grether U; Humm R; Märki HP; Meyer M; Mohr P
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4016-20. PubMed ID: 16737814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARgamma partial agonists.
    Dropinski JF; Akiyama T; Einstein M; Habulihaz B; Doebber T; Berger JP; Meinke PT; Shi GQ
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5035-8. PubMed ID: 16153845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists.
    Lin CH; Peng YH; Coumar MS; Chittimalla SK; Liao CC; Lyn PC; Huang CC; Lien TW; Lin WH; Hsu JT; Cheng JH; Chen X; Wu JS; Chao YS; Lee HJ; Juo CG; Wu SY; Hsieh HP
    J Med Chem; 2009 Apr; 52(8):2618-22. PubMed ID: 19301897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis of tethered ligand dimers for PPARgamma-RXR protein heterodimers.
    Mohler DL; Shen G
    Org Biomol Chem; 2006 Jun; 4(11):2082-7. PubMed ID: 16729120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activities of novel indole derivatives as potent and selective PPARgamma modulators.
    Lamotte Y; Martres P; Faucher N; Laroze A; Grillot D; Ancellin N; Saintillan Y; Beneton V; Gampe RT
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1399-404. PubMed ID: 20079636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonists.
    Shi Q; Canada EJ; Xu Y; Warshawsky AM; Etgen GJ; Broderick CL; Clutinger CK; Irwin LA; Laurila ME; Montrose-Rafizadeh C; Oldham BA; Wang M; Winneroski LL; Xie C; York JS; Yumibe NP; Zink RW; Mantlo N
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6744-9. PubMed ID: 18029178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptophan-containing dipeptide derivatives as potent PPARgamma antagonists: design, synthesis, biological evaluation, and molecular modeling.
    Deng G; Liu Z; Ye F; Luo X; Zhu W; Shen X; Liu H; Jiang H
    Eur J Med Chem; 2008 Dec; 43(12):2699-716. PubMed ID: 18329752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New PPARgamma ligands based on barbituric acid: virtual screening, synthesis and receptor binding studies.
    Sundriyal S; Viswanad B; Ramarao P; Chakraborti AK; Bharatam PV
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4959-62. PubMed ID: 18752947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activities.
    Mahindroo N; Huang CF; Peng YH; Wang CC; Liao CC; Lien TW; Chittimalla SK; Huang WJ; Chai CH; Prakash E; Chen CP; Hsu TA; Peng CH; Lu IL; Lee LH; Chang YW; Chen WC; Chou YC; Chen CT; Goparaju CM; Chen YS; Lan SJ; Yu MC; Chen X; Chao YS; Wu SY; Hsieh HP
    J Med Chem; 2005 Dec; 48(26):8194-208. PubMed ID: 16366601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARgamma agonists.
    Chittiboyina AG; Venkatraman MS; Mizuno CS; Desai PV; Patny A; Benson SC; Ho CI; Kurtz TW; Pershadsingh HA; Avery MA
    J Med Chem; 2006 Jul; 49(14):4072-84. PubMed ID: 16821769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation.
    Ye F; Zhang ZS; Luo HB; Shen JH; Chen KX; Shen X; Jiang HL
    Chembiochem; 2006 Jan; 7(1):74-82. PubMed ID: 16317783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of docosahexaenoic acid derivatives designed as novel PPARgamma agonists and antidiabetic agents.
    Itoh T; Murota I; Yoshikai K; Yamada S; Yamamoto K
    Bioorg Med Chem; 2006 Jan; 14(1):98-108. PubMed ID: 16198578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.